4//SEC Filing
Tubridy Karen L 4
Accession 0001562180-18-001382
CIK 0001517022other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:14 PM ET
Size
7.7 KB
Accession
0001562180-18-001382
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Common Stock
2018-02-28+17,500→ 41,518 total - Award
Employee Stock Option (Right to buy)
2018-02-28+25,000→ 25,000 totalExercise: $14.30Exp: 2028-02-28→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date.
- [F2]The total amount of beneficial securities owned includes 591 shares of stock purchased on June 30, 2017 at $8.92 per share and 427 shares of stock purchased on December 31, 2017 at $12.39 per share in connection with the Issuer's Employee Stock Purchase Plan.
- [F3]The options were granted by the Issuer pursuant to its 2014 Incentive Plan. 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001589888
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:14 PM ET
- Size
- 7.7 KB